Since many years NAFLD has been a matter of study all over the world. NAFLD has been well identified in all medical databases. Strategies for diagnosis and treatment have been reccommended using this nomenclature. Recently a group of experts has proposed the change of name of this entity to MAFLD (metabolic associated fatty liver disease).The reasons for this change undoubtedly have bases. Nevertheless a change of name of a very frequent disease still in the way of study may be a cause of confusion.
Do you think is it the time of change of the name of this disease? Will MAFLD nomenclature progress gaining acceptance?
This name change would make sense. What would you do with NASH? Make it MASH? Would the continum ASH/MASH make more sense than ASH/NASH? Also, the metabolic syndrome includes components that are not closely related to NAFLD, this might be confusing. In any case, thank you for initiating this interesting discussion!
The nomenclature change implies regional validation. In some countries the prevalence with this new one is near 5% but in others of sure is more than 10%
If the change is concerted and adopted by each countries medical order or equivalent (CMA in Canada; Collège des médecins du Québec in the Province of Québec), which are generaly responsible for administrating the exams needed to becoming a doctor, the confusion should be minimal, as it was when the time came to go in French from "omoplate" to "scapula".
- Badges
- Science topic
- Similar topics
- Cognitive Science
- Thinking